| scholarly article | Q13442814 |
| P2093 | author name string | Yan Li | |
| Kai-Wen Peng | |||
| Zhong-He Ji | |||
| P2860 | cites work | Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies | Q26738517 |
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer | Q26774538 | ||
| Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine | Q28255790 | ||
| Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. | Q34009620 | ||
| Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis | Q34015030 | ||
| Early postoperative intraperitoneal chemotherapy for macroscopically serosa-invading gastric cancer patients | Q34043376 | ||
| Hyperthermic intraperitoneal chemotherapy: Rationale and technique | Q34391107 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial | Q34928467 | ||
| Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. | Q35563258 | ||
| Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer | Q35597399 | ||
| Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia | Q35721975 | ||
| Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes | Q36061491 | ||
| Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis | Q36795339 | ||
| Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q37090867 | ||
| Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases | Q38155313 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia | Q38805871 | ||
| What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures | Q38816501 | ||
| A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent | Q38829910 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care | Q38878140 | ||
| Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study | Q39013638 | ||
| Assessment of Hyperthermic Intraperitoneal Chemotherapy to Eradicate Intraperitoneal Free Cancer Cells | Q39225837 | ||
| Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial | Q39995266 | ||
| Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer | Q40358278 | ||
| Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro. | Q40460720 | ||
| Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center | Q40754147 | ||
| Diagnostic value of preoperative RT-PCR-based screening method to detect carcinoembryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer | Q40783113 | ||
| Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis | Q41043049 | ||
| Roles of VLA-2 and VLA-3 on the formation of peritoneal dissemination in gastric cancer | Q41199912 | ||
| Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery | Q43288249 | ||
| A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer | Q43676097 | ||
| A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). | Q43798130 | ||
| Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma | Q43853697 | ||
| Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors | Q43880060 | ||
| Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer | Q44558860 | ||
| Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion | Q45288550 | ||
| Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. | Q45928405 | ||
| Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity. | Q46466258 | ||
| Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study | Q46884398 | ||
| Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center | Q48831086 | ||
| Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. | Q51468726 | ||
| Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. | Q51636076 | ||
| Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study. | Q51747684 | ||
| Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. | Q51831936 | ||
| A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer. | Q53472997 | ||
| Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. | Q54217580 | ||
| The natural history of free cancer cells in the peritoneal cavity. | Q54253432 | ||
| Dissemination of free cancer cells from the gastric lumen and from perigastric lymphovascular pedicles during radical gastric cancer surgery. | Q54380062 | ||
| Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. | Q54790621 | ||
| Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. | Q64882369 | ||
| Intraperitoneal free cancer cells and their viability in gastric cancer | Q66956809 | ||
| Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination | Q67973050 | ||
| [Biologic effects of hyperthermia and radiation on gastric cancer cells (SGC-7901) in vitro. II. Ultrastructural changes of cells] | Q68699607 | ||
| [Biologic effects of hyperthermia and radiation on gastric cancer cells (SGC-7901) in vitro--I. Influence on cell growth curve, number of colonies and mitosis] | Q69056316 | ||
| Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C | Q70369682 | ||
| Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients | Q70590856 | ||
| Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans | Q70721975 | ||
| Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion | Q70783122 | ||
| Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination | Q71110208 | ||
| Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells | Q71957593 | ||
| Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients | Q72388094 | ||
| Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery | Q73090921 | ||
| Recurrence following curative resection for gastric carcinoma | Q73442414 | ||
| Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer | Q75244449 | ||
| Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study | Q77553200 | ||
| Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis | Q78168251 | ||
| Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells | Q78368030 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer | Q80033156 | ||
| The magnitude and time-dependence of the apoptotic response of normal and malignant cells subjected to ionizing radiation versus hyperthermia | Q80242939 | ||
| Impact of intraperitoneal chemotherapy after gastrectomy with positive cytological findings in peritoneal washings | Q82428493 | ||
| Prognostic significance of peritoneal washing cytology in patients with gastric cancer | Q82600895 | ||
| Neoadjuvant treatment of gastric cancer with peritoneal dissemination | Q83169040 | ||
| Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy | Q83903423 | ||
| Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study | Q83955394 | ||
| A possible role of cytokines in the formation of peritoneal dissemination | Q83994565 | ||
| Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis | Q85275232 | ||
| Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial | Q87416761 | ||
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 69 | |
| P577 | publication date | 2016-09-19 | |
| P1476 | title | Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer | |
| P478 | volume | 1 |
Search more.